US Stock MarketDetailed Quotes

Pacira BioSciences (PCRX)

Watchlist
  • 20.670
  • -0.100-0.48%
Close Jan 23 16:00 ET
  • 21.080
  • +0.410+1.98%
Post 17:57 ET
889.25MMarket Cap43.98P/E (TTM)

Pacira BioSciences (PCRX) Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2025
(Q2)Jun 30, 2025
(Q1)Mar 31, 2025
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
12.82%60.83M
-77.44%12.01M
-27.78%35.46M
22.46%189.39M
-30.37%33.13M
21.34%53.92M
22.38%53.24M
156.70%49.1M
6.45%154.65M
13.20%47.58M
Net income from continuing operations
103.79%5.43M
-125.66%-4.85M
-46.41%4.81M
-337.30%-99.56M
-35.50%16.04M
-1,421.29%-143.47M
-26.69%18.89M
145.96%8.98M
163.72%41.96M
346.19%24.87M
Operating gains losses
----
----
----
-144.42%-7.52M
--0
--0
----
----
--16.93M
--0
Depreciation and amortization
4.63%21.19M
44.84%27.32M
14.88%21.17M
4.25%78.79M
14.92%21.24M
9.87%20.25M
-1.00%18.86M
-6.00%18.43M
-17.41%75.57M
-39.21%18.49M
Deferred tax
623.95%8.07M
-94.00%752K
-59.66%1.4M
32.06%20.62M
-46.86%3.51M
-77.31%1.12M
9.55%12.54M
147.17%3.46M
296.54%15.62M
160.89%6.6M
Other non cash items
151.40%1.31M
-77.91%515K
-154.13%-7.7M
-52.62%1.17M
415.93%4.41M
-143.07%-2.54M
113.32%2.33M
-122.93%-3.03M
111.19%2.46M
121.19%854K
Change In working capital
-866.04%-16M
-771.20%-38.2M
-84.91%1.22M
59.55%-18.52M
-55.52%-24.33M
125.46%2.09M
29.39%-4.39M
151.59%8.11M
-178.57%-45.78M
-608.93%-15.65M
-Change in receivables
-121.73%-897K
-205.79%-9.61M
118.51%8.56M
-8.23%-7.75M
-47.12%-12.65M
94.39%4.13M
46.54%-3.14M
-24.56%3.92M
-244.35%-7.16M
-74.56%-8.6M
-Change in inventory
-12.89%-9.51M
-116.30%-14.4M
-211.89%-8.47M
-152.46%-20.93M
-71.29%-13.42M
-91.96%-8.43M
-885.95%-6.66M
145.37%7.57M
-433.47%-8.29M
-1,165.71%-7.83M
-Change in prepaid assets
193.94%4.72M
-422.39%-11.52M
-892.75%-7.11M
23.64%-7.36M
61.48%-1.02M
-92.17%-5.03M
9.70%-2.21M
146.57%897K
-257.13%-9.64M
-24.50%-2.65M
-Change in payables and accrued expense
-137.92%-4.48M
-263.62%-12.5M
304.45%7.17M
170.08%14.8M
-137.80%-1.15M
483.83%11.82M
444.02%7.64M
84.42%-3.51M
-55.49%-21.12M
-42.48%3.05M
-Change in other current liabilities
-1,338.52%-5.83M
51,800.00%9.82M
240.34%1.08M
525.35%2.71M
892.13%3.91M
-70.17%-405K
86.71%-19K
-283.14%-771K
178.06%434K
133.42%394K
Cash from discontinued investing activities
Operating cash flow
12.82%60.83M
-77.44%12.01M
-27.78%35.46M
22.46%189.39M
-30.37%33.13M
21.34%53.92M
22.38%53.24M
156.70%49.1M
6.45%154.65M
13.20%47.58M
Investing cash flow
Cash flow from continuing investing activities
183.61%43.61M
508.56%62.16M
-65.03%-25.63M
-207.40%-83.28M
-104.39%-368K
-1,101.36%-52.16M
-307.68%-15.22M
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
Net PPE purchase and sale
5.43%-3.87M
-69.62%-2.7M
-201.41%-8.55M
29.85%-10.64M
-17.80%-2.12M
-20.57%-4.09M
53.29%-1.59M
56.80%-2.84M
49.59%-15.16M
67.26%-1.8M
Net business purchase and sale
--0
--0
---16.7M
--0
--0
--0
--0
--0
--0
----
Net investment purchase and sale
198.78%47.48M
576.04%64.86M
97.01%-379K
-178.36%-72.64M
-82.80%1.75M
-4,970.78%-48.07M
-226.98%-13.63M
-117.45%-12.69M
156.83%92.7M
-39.02%10.17M
Cash from discontinued investing activities
Investing cash flow
183.61%43.61M
508.56%62.16M
-65.03%-25.63M
-207.40%-83.28M
-104.39%-368K
-1,101.36%-52.16M
-307.68%-15.22M
-123.47%-15.53M
134.43%77.54M
-25.16%8.37M
Financing cash flow
Cash flow from continuing financing activities
-8,950.12%-257.48M
-330.20%-57.51M
-6.28%-2.99M
109.49%17.36M
-9.89%-1.96M
89.76%-2.85M
5,577.27%24.98M
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
Net issuance payments of debt
-7,195.98%-205.24M
-104.41%-3.75M
0.00%-2.81M
142.38%76.62M
0.00%-2.81M
89.89%-2.81M
3,123.57%85.05M
98.09%-2.81M
57.74%-180.76M
95.26%-2.81M
Net common stock issuance
---50.04M
----
----
---25M
--0
--0
----
----
--0
--0
Proceeds from stock option exercised by employees
100.04%12K
----
----
-51.62%2.3M
2,326.95%27.64M
-106,936.00%-26.71M
-58.07%1.36M
--0
-82.63%4.75M
-44.14%1.14M
Net other financing activities
-108.29%-2.21M
85.50%-5.29M
-4,425.00%-181K
-420.73%-36.55M
-25,169.81%-26.79M
--26.68M
---36.44M
99.94%-4K
-497.36%-7.02M
---106K
Cash from discontinued financing activities
Financing cash flow
-8,950.12%-257.48M
-330.20%-57.51M
-6.28%-2.99M
109.49%17.36M
-9.89%-1.96M
89.76%-2.85M
5,577.27%24.98M
98.17%-2.82M
54.42%-183.03M
96.96%-1.78M
Net cash flow
Beginning cash position
21.63%300.48M
54.09%283.61M
80.55%276.77M
47.21%153.3M
148.15%245.97M
184.59%247.05M
417.80%184.05M
47.21%153.3M
-82.22%104.14M
-9.42%99.12M
Current changes in cash
-13,965.07%-153.03M
-73.54%16.67M
-77.77%6.84M
151.18%123.48M
-43.13%30.81M
-108.84%-1.09M
22.89%63M
144.83%30.75M
110.21%49.16M
1,125.15%54.18M
Effect of exchange rate changes
--133K
----
----
----
----
--0
----
----
----
----
End cash Position
-40.00%147.59M
21.63%300.48M
54.09%283.61M
80.55%276.77M
80.55%276.77M
148.15%245.97M
184.59%247.05M
417.80%184.05M
47.21%153.3M
47.21%153.3M
Free cash flow
14.32%56.96M
-81.96%9.32M
-41.83%26.91M
28.15%178.75M
-32.26%31.01M
21.40%49.83M
28.81%51.65M
268.26%46.27M
21.09%139.49M
25.29%45.79M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2025(Q2)Jun 30, 2025(Q1)Mar 31, 2025(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 12.82%60.83M-77.44%12.01M-27.78%35.46M22.46%189.39M-30.37%33.13M21.34%53.92M22.38%53.24M156.70%49.1M6.45%154.65M13.20%47.58M
Net income from continuing operations 103.79%5.43M-125.66%-4.85M-46.41%4.81M-337.30%-99.56M-35.50%16.04M-1,421.29%-143.47M-26.69%18.89M145.96%8.98M163.72%41.96M346.19%24.87M
Operating gains losses -------------144.42%-7.52M--0--0----------16.93M--0
Depreciation and amortization 4.63%21.19M44.84%27.32M14.88%21.17M4.25%78.79M14.92%21.24M9.87%20.25M-1.00%18.86M-6.00%18.43M-17.41%75.57M-39.21%18.49M
Deferred tax 623.95%8.07M-94.00%752K-59.66%1.4M32.06%20.62M-46.86%3.51M-77.31%1.12M9.55%12.54M147.17%3.46M296.54%15.62M160.89%6.6M
Other non cash items 151.40%1.31M-77.91%515K-154.13%-7.7M-52.62%1.17M415.93%4.41M-143.07%-2.54M113.32%2.33M-122.93%-3.03M111.19%2.46M121.19%854K
Change In working capital -866.04%-16M-771.20%-38.2M-84.91%1.22M59.55%-18.52M-55.52%-24.33M125.46%2.09M29.39%-4.39M151.59%8.11M-178.57%-45.78M-608.93%-15.65M
-Change in receivables -121.73%-897K-205.79%-9.61M118.51%8.56M-8.23%-7.75M-47.12%-12.65M94.39%4.13M46.54%-3.14M-24.56%3.92M-244.35%-7.16M-74.56%-8.6M
-Change in inventory -12.89%-9.51M-116.30%-14.4M-211.89%-8.47M-152.46%-20.93M-71.29%-13.42M-91.96%-8.43M-885.95%-6.66M145.37%7.57M-433.47%-8.29M-1,165.71%-7.83M
-Change in prepaid assets 193.94%4.72M-422.39%-11.52M-892.75%-7.11M23.64%-7.36M61.48%-1.02M-92.17%-5.03M9.70%-2.21M146.57%897K-257.13%-9.64M-24.50%-2.65M
-Change in payables and accrued expense -137.92%-4.48M-263.62%-12.5M304.45%7.17M170.08%14.8M-137.80%-1.15M483.83%11.82M444.02%7.64M84.42%-3.51M-55.49%-21.12M-42.48%3.05M
-Change in other current liabilities -1,338.52%-5.83M51,800.00%9.82M240.34%1.08M525.35%2.71M892.13%3.91M-70.17%-405K86.71%-19K-283.14%-771K178.06%434K133.42%394K
Cash from discontinued investing activities
Operating cash flow 12.82%60.83M-77.44%12.01M-27.78%35.46M22.46%189.39M-30.37%33.13M21.34%53.92M22.38%53.24M156.70%49.1M6.45%154.65M13.20%47.58M
Investing cash flow
Cash flow from continuing investing activities 183.61%43.61M508.56%62.16M-65.03%-25.63M-207.40%-83.28M-104.39%-368K-1,101.36%-52.16M-307.68%-15.22M-123.47%-15.53M134.43%77.54M-25.16%8.37M
Net PPE purchase and sale 5.43%-3.87M-69.62%-2.7M-201.41%-8.55M29.85%-10.64M-17.80%-2.12M-20.57%-4.09M53.29%-1.59M56.80%-2.84M49.59%-15.16M67.26%-1.8M
Net business purchase and sale --0--0---16.7M--0--0--0--0--0--0----
Net investment purchase and sale 198.78%47.48M576.04%64.86M97.01%-379K-178.36%-72.64M-82.80%1.75M-4,970.78%-48.07M-226.98%-13.63M-117.45%-12.69M156.83%92.7M-39.02%10.17M
Cash from discontinued investing activities
Investing cash flow 183.61%43.61M508.56%62.16M-65.03%-25.63M-207.40%-83.28M-104.39%-368K-1,101.36%-52.16M-307.68%-15.22M-123.47%-15.53M134.43%77.54M-25.16%8.37M
Financing cash flow
Cash flow from continuing financing activities -8,950.12%-257.48M-330.20%-57.51M-6.28%-2.99M109.49%17.36M-9.89%-1.96M89.76%-2.85M5,577.27%24.98M98.17%-2.82M54.42%-183.03M96.96%-1.78M
Net issuance payments of debt -7,195.98%-205.24M-104.41%-3.75M0.00%-2.81M142.38%76.62M0.00%-2.81M89.89%-2.81M3,123.57%85.05M98.09%-2.81M57.74%-180.76M95.26%-2.81M
Net common stock issuance ---50.04M-----------25M--0--0----------0--0
Proceeds from stock option exercised by employees 100.04%12K---------51.62%2.3M2,326.95%27.64M-106,936.00%-26.71M-58.07%1.36M--0-82.63%4.75M-44.14%1.14M
Net other financing activities -108.29%-2.21M85.50%-5.29M-4,425.00%-181K-420.73%-36.55M-25,169.81%-26.79M--26.68M---36.44M99.94%-4K-497.36%-7.02M---106K
Cash from discontinued financing activities
Financing cash flow -8,950.12%-257.48M-330.20%-57.51M-6.28%-2.99M109.49%17.36M-9.89%-1.96M89.76%-2.85M5,577.27%24.98M98.17%-2.82M54.42%-183.03M96.96%-1.78M
Net cash flow
Beginning cash position 21.63%300.48M54.09%283.61M80.55%276.77M47.21%153.3M148.15%245.97M184.59%247.05M417.80%184.05M47.21%153.3M-82.22%104.14M-9.42%99.12M
Current changes in cash -13,965.07%-153.03M-73.54%16.67M-77.77%6.84M151.18%123.48M-43.13%30.81M-108.84%-1.09M22.89%63M144.83%30.75M110.21%49.16M1,125.15%54.18M
Effect of exchange rate changes --133K------------------0----------------
End cash Position -40.00%147.59M21.63%300.48M54.09%283.61M80.55%276.77M80.55%276.77M148.15%245.97M184.59%247.05M417.80%184.05M47.21%153.3M47.21%153.3M
Free cash flow 14.32%56.96M-81.96%9.32M-41.83%26.91M28.15%178.75M-32.26%31.01M21.40%49.83M28.81%51.65M268.26%46.27M21.09%139.49M25.29%45.79M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Market Insights
Nancy Pelosi Portfolio
China Concept Stocks
View More
The Fed Delivers Third Consecutive Rate Cut as Expected! How to Position for Year-End U.S. Equity Ma
On December 19, the Bank of Japan raised interest rates by 25 basis points as expected, in line with market forecasts. On the evening of Dec Show More